394 related articles for article (PubMed ID: 24849045)
1. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ
JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045
[TBL] [Abstract][Full Text] [Related]
2. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
[TBL] [Abstract][Full Text] [Related]
3. Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.
Katz SJ; Hawley ST; Hamilton AS; Ward KC; Morrow M; Jagsi R; Hofer TP
JAMA Surg; 2018 Jan; 153(1):29-36. PubMed ID: 28903158
[TBL] [Abstract][Full Text] [Related]
4. Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
Lizarraga IM; Schroeder MC; Jatoi I; Sugg SL; Trentham-Dietz A; Hoeth L; Chrischilles EA
Ann Surg Oncol; 2021 Dec; 28(13):8752-8765. PubMed ID: 34251554
[TBL] [Abstract][Full Text] [Related]
5. The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients.
Hawley ST; Griffith KA; Hamilton AS; Ward KC; Morrow M; Janz NK; Katz SJ; Jagsi R
Cancer; 2017 Dec; 123(23):4547-4555. PubMed ID: 28810062
[TBL] [Abstract][Full Text] [Related]
6. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.
Hawley ST; Griggs JJ; Hamilton AS; Graff JJ; Janz NK; Morrow M; Jagsi R; Salem B; Katz SJ
J Natl Cancer Inst; 2009 Oct; 101(19):1337-47. PubMed ID: 19720966
[TBL] [Abstract][Full Text] [Related]
7. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
[TBL] [Abstract][Full Text] [Related]
8. Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.
Katz SJ; Janz NK; Abrahamse P; Wallner LP; Hawley ST; An LC; Ward KC; Hamilton AS; Morrow M; Jagsi R
JAMA Surg; 2017 Jul; 152(7):658-664. PubMed ID: 28384687
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Satisfaction and Body Image After Contralateral Prophylactic Mastectomy.
Anderson C; Islam JY; Elizabeth Hodgson M; Sabatino SA; Rodriguez JL; Lee CN; Sandler DP; Nichols HB
Ann Surg Oncol; 2017 Jun; 24(6):1499-1506. PubMed ID: 28058563
[TBL] [Abstract][Full Text] [Related]
10. Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer.
Jagsi R; Abrahamse P; Morrow M; Hawley ST; Griggs JJ; Graff JJ; Hamilton AS; Katz SJ
J Clin Oncol; 2010 May; 28(14):2396-403. PubMed ID: 20351324
[TBL] [Abstract][Full Text] [Related]
11. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.
Dragun AE; Pan J; Riley EC; Kruse B; Wilson MR; Rai S; Jain D
Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566
[TBL] [Abstract][Full Text] [Related]
12. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
Agarwal S; Pappas L; Matsen CB; Agarwal JP
Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
14. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
[TBL] [Abstract][Full Text] [Related]
15. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.
Christian N; Zabor EC; Cassidy M; Flynn J; Morrow M; Gemignani ML
Ann Surg Oncol; 2020 Mar; 27(3):743-749. PubMed ID: 31732944
[TBL] [Abstract][Full Text] [Related]
16. Trends in Sexual Function After Breast Cancer Surgery.
Cornell LF; Mussallem DM; Gibson TC; Diehl NN; Bagaria SP; McLaughlin SA
Ann Surg Oncol; 2017 Sep; 24(9):2526-2538. PubMed ID: 28560595
[TBL] [Abstract][Full Text] [Related]
17. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
Pinell-White XA; Kolegraff K; Carlson GW
Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
[TBL] [Abstract][Full Text] [Related]
18. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
Huang J; Chagpar A
J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
[TBL] [Abstract][Full Text] [Related]
19. Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics.
Rahbar H; Hanna LG; Gatsonis C; Mahoney MC; Schnall MD; DeMartini WB; Lehman CD
Radiology; 2014 Oct; 273(1):53-60. PubMed ID: 24937691
[TBL] [Abstract][Full Text] [Related]
20. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
